News

Technology News

CVRx Launches Heart Failure Device Trial

Friday, August 26, 2011 5:01:00 AM PDT | VentureDeal Staff
Minneapolis, Minnesota  --  Medical device company CVRx has announced the launch of a clinical trial for its second-generation heart failure implantable device.

Called the Barostim neo, the device promises to allow for a more focused and efficient delivery of electric stimulation of the heart, shorter procedure times and greater longevity.

The trial is being conducted in Europe and Canada and the company plans to share the latest results on Tuesday, August 30.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1